Literature DB >> 30655282

Therapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trials.

Vincent Cottin1, Arata Azuma2, Ganesh Raghu3, Wibke Stansen4, Susanne Stowasser5, Rozsa Schlenker-Herceg6, Martin Kolb7.   

Abstract

Entities:  

Year:  2019        PMID： 30655282     DOI： 10.1183/13993003.01655-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  6 in total

1.  Clinical Features and Outcomes of Combined Pulmonary Fibrosis and Emphysema After Lung Transplantation.

Authors:  Tsuyoshi Takahashi; Yuriko Terada; Michael K Pasque; Jingxia Liu; Derek E Byers; Chad A Witt; Ruben G Nava; Varun Puri; Benjamin D Kozower; Bryan F Meyers; Daniel Kreisel; G Alexander Patterson; Ramsey R Hachem
Journal:  Chest       Date:  2021-06-26       Impact factor: 9.410

Review 2.  Management of Idiopathic Pulmonary Fibrosis.

Authors:  Roy Pleasants; Robert M Tighe
Journal:  Ann Pharmacother       Date:  2019-07-07       Impact factor: 3.154

Review 3.  Combined Pulmonary Fibrosis and Emphysema (CPFE) Clinical Features and Management.

Authors:  René Hage; Fiorenza Gautschi; Carolin Steinack; Macé M Schuurmans
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-01-28

Review 4.  Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease.

Authors:  Joon Young Choi; Jin Woo Song; Chin Kook Rhee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2022-01-27

5.  Combined Pulmonary Fibrosis Emphysema: Role of Cigarette Smoking and Pulmonary Hypertension in a Rural Cohort.

Authors:  Rahul Sangani; Andrew Ghio; Stacey Culp; Zalak Patel; Sunil Sharma
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-06-21

Review 6.  Ongoing challenges in pulmonary fibrosis and insights from the nintedanib clinical programme.

Authors:  Claudia Valenzuela; Sebastiano Emanuele Torrisi; Nicolas Kahn; Manuel Quaresma; Susanne Stowasser; Michael Kreuter
Journal:  Respir Res       Date:  2020-01-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.